LAMTOR3 and rhabdomyosarcoma: The requirement for LAMTOR3 in EV71-induced cell death was further confirmed in human rhabdomyosarcoma RD cells (Fig. 1 E), where deletion of LAMTOR3 also efficiently reduced the percentage of PI-positive cells after EV71 infection (Fig. 1 F).